DARWIN EU ID: P4-C1-021
HMA-EMA Study Catalogue: EUPAS-EUPAS1000000826
Results Explorer: Web Application
Study Description:
Alzheimer’s disease (AD) is the most common cause of dementia, characterised by progressive cognitive decline and loss of independence. Its burden is rising globally due to population ageing, with substantial implications for healthcare systems and society. Recent therapeutic advances, such as the approval of anti amyloid monoclonal antibodies, are reshaping AD management but also highlight the need for comprehensive and updated real-world evidence on the epidemiology and characteristics of affected populations. This DARWIN EU® study will provide contextual information through a comprehensive overview of the incidence and prevalence of AD in the general adult population in European countries, as well as demographic and clinical characteristics of individuals with AD.
Instructions:
The instructions on how to run the study code are provided in the instructions.md file.
Disclaimer:
This study code is developed for execution on the selected data sources of the DARWIN EU Data Network as described in the study protocol. While the DARWIN EU Coordination Centre does not provide support to external users of this code, we welcome feedback via our email address (enquiries@darwin-eu.org).
License:
This software is distributed under the Apache License 2.0 on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
For more information about DARWIN EU® see www.darwin-eu.org.
Copyright 2025 European Medicines Agency.